Non-Esterified Fatty Acid Reagents Market Segmented By Application such as Diabetes, Obesity, Lipid Metabolism Disorders, Malignant Diseases, Metabolic Syndrome with Sample Type in Serum, Plasma, Tissue Homogenate and Cells or Cell Supernatant
Industry: Healthcare
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Report Type: Ongoing
Report ID: PMRREP30673
Non-esterified fatty acids are the molecules released from triglycerides as a result of enzyme lipase action which is then transported in the blood bound to albumin. Management of non-esterified fatty acids level is important in diabetic patients and the levels are also frequently increasing among the obese population.
The rising patient pool is likely to drive the non-esterified fatty acid testing and will be furthered propel the growth of non-esterified fatty acid reagent market. The fluctuation of the insulin level and poor diet will adversely affect the release of non-esterified fatty acids in the body which may develop cardiovascular disease.
Conditions like diabetes type 2/ insulin resistance, obesity, metabolic syndrome, and malignant diseases all are related to increased non-esterified fatty acids concentrations in the blood. This factor will boost the need for non-esterified fatty acid testing and is likely to contribute to the non-esterified fatty acid reagent market growth.
Additionally, from past few years, awareness has been raised among these population group which is likely to contribute to the growth of the non-esterified fatty acid reagent market.
According to the International Diabetes Federation, The diabetic population is expected to rise to 600 Mn by 2045. Around 79% of diabetic adults’ are from low- & middle-income countries. This factor will increase the non-esterified fatty acid testing and is likely to contribute to the non-esterified fatty acid reagent market growth.
Healthcare professionals recommend diabetic patients to regularly check body fat which will increase the testing demand and will boost the non-esterified fatty acid reagent market growth. According to the World Health Organization, approximately 1.9 Bn population aged 18 years and above were overweight, in 2016, globally.
The increasing obese population is expected to boost the need for non-esterified fatty acid testing and is expected to contribute to the non-esterified fatty acid reagent market growth over the coming years.
| by Application |
|
| by Sample Type |
|
| by End User |
|
A non-esterified fatty acid is produced by the hydrolysis of fats and oils. To detect the level non-esterified fatty acid reagents and assay kits are required. Non-esterified fatty acid reagents are expected to show high revenue growth for the global non-esterified fatty acid reagents market due to the rising ageing population and poor lifestyle especially among adults and young age population.
According to the World Health Organization, the prevalence rate of obesity approximately triplicated between 1975 and 2016 worldwide. This factor has increased the non-esterified fatty acid testing and boosted the growth of non-esterified fatty acid reagent market. Moreover, the on-esterified fatty acid reagent market is likely to experience significant growth opportunities in the coming years because of rising patient pool.
The North America non-esterified fatty acid reagents market is expected to be a prominent market and is estimated to show high market growth owing to progressive clinical diagnostic infrastructure and resources in the region. The non-esterified fatty acid reagents market in Europe region is expected to be the lucrative market for non-esterified fatty acid reagents.
The non-esterified fatty acid reagents market in the Asia Pacific region is likely to show a high growth due to presence of high market opportunity in the non-esterified fatty acid reagents market. The large number of underserved population is likely to fuel the growth of the non-esterified fatty acid reagents market.
Some of the key players in the non-esterified fatty acid reagents market include Sekisui Diagnostics (Sekisui Chemical), FUJIFILM Wako Diagnostics USA Corporation, Randox Laboratories, Biocompare, Cell Biolabs, Inc., Amsbio LLC (AMS Biotechnology (Europe) Ltd), IGZ Instruments AG, Sigma-Aldrich Corporation, Weldon Biotech India Pvt. Ltd., Instruchemie B.V., Pacific Biomarkers Inc (Neomed-Labs Inc), Cedarlane, Elabscience, and others.
To know more about delivery timeline for this report Contact Sales
